Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-γ pathway
- 12 March 2008
- journal article
- Published by Elsevier in Life Sciences
- Vol. 82 (11-12), 561-569
- https://doi.org/10.1016/j.lfs.2007.11.033
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged BoneEndocrinology, 2007
- Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblastsBiochemical and Biophysical Research Communications, 2005
- Glucocorticoid-Induced Osteoporosis: Both In Vivo and In Vitro Concentrations of Glucocorticoids Higher Than Physiological Levels Attenuate Osteoblast DifferentiationJournal of Bone and Mineral Research, 1998
- Human Trabecular Bone Cells Are Able to Express Both Osteoblastic and Adipocytic Phenotype: Implications for Osteopenic DisordersJournal of Bone and Mineral Research, 1998
- Early increase in plama parathyroid hormone levels following liver transplantationJournal of Hepatology, 1996
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genesJournal of Cellular Biochemistry, 1992
- Histologic evidence for osteopenia and increased bone turnover in ovariectomized ratsBone, 1986
- Hormonal responsiveness of a preadipose cell line derived from newborn mouse calvariaJournal of Cellular Physiology, 1982
- Osteoporosis and the Replacement of Cell Populations of the Marrow by Adipose TissueClinical Orthopaedics and Related Research, 1971